Ulys A, Cerniauskiene A, Geavlete P, Larsen F, et al. Teverelix is a potential treatment option for the prevention of acute urinary
retention recurrence in men suffering from benign prostatic hyperplasia. Int Urol Nephrol 2024 Oct 20. doi: 10.1007/s11255-024-04235.
PMID: 39428443
![]() |
![]() |
![]() |